Biocompatibility evaluation of heparin-conjugated poly(ε-caprolactone) scaffolds in a rat subcutaneous implantation model

J Mater Sci Mater Med. 2020 Aug 5;31(8):76. doi: 10.1007/s10856-020-06419-0.

Abstract

Vascular grafts prepared from synthetic polymers have serious shortcomings that can be resolved by surface modification, such as by immobilizing heparin. In this study, the mechanical properties, biocompatibility, anticoagulation property, and water contact angle of two heparin-conjugated poly(ε-caprolactone) scaffolds (PCL-hexamethylendiamine-heparin, PCL-HMD-H. PCL-lysine-heparin, PCL-LYS-H) were compared to identify a preferred heparin conjugation method. An evaluation of the subcutaneous tissue biocompatibility of the scaffolds demonstrated that PCL-HMD-H had better endothelial cell proliferation than the PCL-LYS-H and was therefore a promising scaffold candidate for use in vascular tissue-engineering.

MeSH terms

  • Animals
  • Blood Vessel Prosthesis / adverse effects
  • Cell Adhesion / drug effects
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Heparin / chemistry*
  • Heparin / pharmacology
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Male
  • Materials Testing
  • Models, Animal
  • Polyesters / chemistry*
  • Polyesters / pharmacology
  • Polymers / chemistry
  • Polymers / pharmacology
  • Prosthesis Implantation / methods
  • Rats
  • Rats, Wistar
  • Subcutaneous Tissue / drug effects*
  • Tissue Engineering / methods
  • Tissue Scaffolds* / adverse effects
  • Tissue Scaffolds* / chemistry

Substances

  • Polyesters
  • Polymers
  • polycaprolactone
  • Heparin